Department of Orthopaedics, University of Utah, Salt Lake City, UT.
Division of Public Health, University of Utah, Salt Lake City, UT.
J Hand Surg Am. 2020 May;45(5):399-407.e6. doi: 10.1016/j.jhsa.2019.12.002. Epub 2020 Jan 16.
The minimal clinically important difference (MCID) is used in research and clinical settings as a benchmark to gauge improvement following treatment. The purpose of this study was to provide anchor-based MCID estimates for Patient-Reported Outcomes Measurement Information System (PROMIS) and legacy instruments in a nonshoulder hand and upper extremity population.
Adult patients (≥18 years) seeking care at a tertiary academic outpatient hand surgery clinic completed patient-reported outcome measures on tablet computers between January 2015 and August 2017. Data were collected at baseline and at 6 ± 2 weeks of follow-up. The PROMIS Upper Extremity (UE), Physical Function (PF), and Pain Interference (PI) Computer Adaptive Test (CAT) instruments were administered, along with the shortened Disabilities of the Arm, Shoulder, and Hand (QuickDASH). A mean change anchor-based method was used to estimate MCIDs by comparing scores between anchor groups reporting no change versus slightly improved in terms of function and pain.
Scores for each instrument significantly improved over the study period. With significant differences in scores between groups reporting no change and slightly improved function, anchor-based MCID estimates were calculated as follows: 2.1 for the PROMIS UE CAT, 1.7 for the PROMIS PF CAT, and 6.8 for the QuickDASH. There was no significant difference in PROMIS PI CAT scores between anchor groups when queried for level of pain improvement, precluding estimation of an anchor-based MCID.
We have provided anchor-based MCID estimates for the PROMIS UE CAT, PROMIS PF CAT, and the QuickDASH for a general nonshoulder hand and upper extremity population. These values may be useful in future research for informing power calculations and when interpreting whether the magnitude of change on these instruments is clinically significant at a population level.
This study provides clinicians with a reference for values that may reflect clinically meaningful changes in scores for patient-reported outcome instruments commonly utilized in the current hand surgery literature.
最小临床重要差异(MCID)在研究和临床环境中被用作衡量治疗后改善的基准。本研究的目的是为非肩部手部和上肢人群提供患者报告的结局测量信息系统(PROMIS)和传统工具的基于锚定的 MCID 估计值。
2015 年 1 月至 2017 年 8 月期间,在一家三级学术门诊手外科诊所就诊的成年患者(≥18 岁)在平板电脑上完成了患者报告的结局测量。数据在基线和 6±2 周随访时收集。进行了 PROMIS 上肢(UE)、躯体功能(PF)和疼痛干扰(PI)计算机自适应测试(CAT)工具,以及缩短版的上肢残障问卷(QuickDASH)。使用基于均值变化的锚定方法,通过比较报告功能和疼痛略有改善与无变化的锚定组之间的分数,来估计 MCID。
每个工具的分数在研究期间均显著提高。报告功能无变化和略有改善的两组之间的分数存在显著差异,因此计算了基于锚定的 MCID 估计值:PROMIS UE CAT 为 2.1,PROMIS PF CAT 为 1.7,QuickDASH 为 6.8。当询问疼痛改善程度时,PROMIS PI CAT 分数在锚定组之间没有显著差异,因此无法估计基于锚定的 MCID。
我们为一般非肩部手部和上肢人群提供了基于锚定的 PROMIS UE CAT、PROMIS PF CAT 和 QuickDASH 的 MCID 估计值。这些值在未来的研究中可能有助于告知功效计算,并在解释这些工具的变化程度在人群水平上是否具有临床意义时使用。
本研究为临床医生提供了一个参考值,该值可能反映了当前手部外科文献中常用的患者报告结局工具的分数中具有临床意义的变化。